EODData

FRA, 2M7C: China Medical System Holdings Limited

06 Oct 2025
LAST:

1.510

CHANGE:
 0.00
OPEN:
1.510
HIGH:
1.510
ASK:
0.000
VOLUME:
1.4K
CHG(%):
0.00
PREV:
1.510
LOW:
1.510
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Oct 251.5101.5101.5101.5101.4K
02 Oct 251.5101.5101.5101.5101.4K
01 Oct 251.5001.5001.5001.5000
30 Sep 251.5001.5001.5001.5000
29 Sep 251.4901.4901.4901.4901.4K
26 Sep 251.5501.5501.5401.5401.4K
25 Sep 251.5501.5501.5501.5501.4K
24 Sep 251.6001.6001.6001.6001.4K
23 Sep 251.6001.6301.6001.6301.4K
22 Sep 251.5701.5701.5701.5701.4K

COMPANY PROFILE

Name:China Medical System Holdings Limited
About:China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate depression. It also provides gastroenterology products, such as METOJECT, a methotrexate injection to treat severe recalcitrant disabling psoriasis and rheumatoid arthritis; LUMEBLUE, a methylthioninium chloride enteric-coated sustained-release tablets for colorectal lesion visualization; Salofalk for ulcerative colitis and Crohn's disease; Bioflor, a saccharomyces boulardii sachets for diarrhea; Combizym and Cidine for digestive enzymes; and Ursofalk, a ursodeoxycholic acid capsules to treat cholesterol gallstones. In addition, the company offers dermatology products, including ILUMETRI, a tildrakizumab injection for the treatment of plaque psoriasis; Aethoxysklerol, a polidocanol injection for sclerotherapy of various varicose veins; Hirudoid, a mucopolysaccharide polysulfate cream to treat blunt traumata; skin heling soothing product; and Hirudoid for acne-prone skin care, prevention, and enhancement of acne. Further, it provides Vmonalisa, modified sodium hyaluronate filler for mid to deep dermal implantation; augentropfen stulln mono eye drops for asthenopia; EyeOP1 glaucoma treatment device; and Elcitonin for Osteoporosis pain. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
Sector:Healthcare
Address:Island Place Tower, North Point, Hong Kong
Website:https://web.cms.net.cn/zh/home/
ISIN:KYG211081248
LEI:529900Z57DVJXUBLHX66

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:18.38
DivYield:0.19
Div/Share:0.27
Price to Book:1.76
Price to Sales:0.47
EBITDA:1.895B
Shares:2.44B
Market Cap:3.684B

TECHNICAL INDICATORS

MA5:1.50
MA10:1.54
MA20:1.55
MA50:1.49
MA100:1.36
MA200:1.13
STO9:14.29
STO14:12.50
RSI14:35.29
WPR14:-87.50
MTM14:-0.14
ROC14:-0.08
ATR:0.03
Week High:1.51
Week Low:1.49
Month High:1.65
Month Low:1.49
Year High:1.65
Year Low:0.80
Volatility:22.90

RECENT SPLITS

Date Ratio
27 Apr 20123-2

RECENT DIVIDENDS

Date Amount
28 Apr 2025$0.01
29 Aug 2024$0.02
13 May 2024$0.01
11 Sep 2023$0.04
03 May 2023$0.03
05 Sep 2022$0.04
26 Apr 2022$0.03
06 Sep 2021$0.03
29 Apr 2021$0.03
26 Aug 2020$0.03